Product image of Laxido Laranja (Sodium Hydrogen Carbonate, Potassium Chloride, Sodium Chloride, Macrogol 3350) supplied by GNH India

Laxido Laranja

Active Ingredient:
Sodium Hydrogen Carbonate, Potassium Chloride, Sodium Chloride, Macrogol 3350
Origin:
EU

Laxido Laranja (Sodium Hydrogen Carbonate, Potassium Chloride, Sodium Chloride, Macrogol 3350)

Polyethylene glycol 3350 with electrolytes, the active ingredient in Laxido Laranja, is an osmotic laxative presented as an unspecified strength powder for oral solution use. It is used to relieve constipation and to prepare the bowel for diagnostic procedures in adults and children.

GNH India supplies Laxido Laranja as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Intergal Pharma Ireland Limited

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Laxido Laranja is an osmotic laxative indicated for conditions affecting bowel motility and preparation.

  • Constipation: softens stool and promotes regular bowel movements.
  • Bowel preparation for diagnostic procedures: clears the intestinal tract to improve visualization during colonoscopy or imaging.
  • Delayed gastrointestinal transit: facilitates transit by increasing luminal water content.

How It Works

  • Polyethylene glycol 3350 with electrolytes acts as an osmotic agent that retains water within the intestinal lumen by creating an osmotic gradient. The increased water content softens fecal mass and expands the stool volume, stimulating peristalsis and accelerating colonic transit without being absorbed systemically.

Side Effects

Laxido Laranja may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects

  • Abdominal bloating: sensation of fullness or swelling in the abdomen.
  • Flatulence: increased intestinal gas.
  • Nausea: feeling of queasiness.
  • Diarrhea: loose, watery stools.
  • Stomach cramps: intermittent abdominal pain.
  • Increased thirst: feeling of needing to drink more fluids.

Serious or Rare Side Effects

  • Severe electrolyte imbalance: abnormal sodium, potassium, or chloride levels.
  • Allergic reaction: rash, itching, swelling, or difficulty breathing.
  • Severe dehydration: excessive loss of body fluids.
  • Intestinal obstruction: blockage of the bowel.
  • Severe abdominal pain: persistent, intense pain requiring medical attention.

Precautions & Warnings

Before using Laxido Laranja, consider the following safety measures.

  • Assess renal function: avoid or adjust use in patients with severe renal impairment.
  • Monitor electrolytes: especially in individuals at risk of electrolyte disturbances.
  • Use with caution in children: follow pediatric dosing recommendations.
  • Avoid prolonged use: limit to short‑term therapy unless directed by a healthcare professional.
  • Pregnancy and lactation: consult a healthcare provider before use.
  • Store at ambient temperature: keep in the original container, protect from moisture.

Avoid Interactions

Laxido Laranja can interact with other medications and substances that affect fluid or electrolyte balance.

Major Interactions (Avoid)

  • Concurrent use with other osmotic laxatives: risk of severe electrolyte disturbances.
  • High‑dose mineral supplements (e.g., sodium or potassium): may cause hypernatremia or hyperkalemia.

Moderate Interactions (Monitor Closely)

  • Diuretics: monitor electrolyte levels during combined therapy.
  • ACE inhibitors or ARBs: watch for potassium changes.
  • Antacids containing sodium: assess total sodium intake.
  • Oral rehydration solutions: adjust dosing to prevent fluid overload.

Frequently Asked Questions

Laxido Laranja is an oral powder that contains polyethylene glycol 3350 with electrolytes. It is used to relieve occasional constipation and to prepare the bowel for diagnostic procedures such as colonoscopy by softening stool and increasing intestinal water content.

The polyethylene glycol component creates an osmotic gradient that draws water into the intestinal lumen, while the added electrolytes help maintain fluid balance. This combination softens the stool and promotes faster transit through the colon without being absorbed into the bloodstream.

The appropriate dose of Laxido Laranja is determined by a prescriber based on the patient’s age, weight, and clinical condition. Healthcare professionals calculate the amount of powder to dissolve in water and the frequency of administration for each individual case.

Safety data for Laxido Laranja in pregnancy and lactation are limited. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss potential risks and benefits with their healthcare provider before using this product.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, and will request trade or institutional credentials before providing pricing, availability, shipping details and any necessary import documentation.

Compared with stimulant laxatives, Laxido Laranja works by osmotic action rather than stimulating intestinal muscles, which often results in fewer cramping side effects. Unlike simple fiber supplements, it provides a rapid increase in luminal water and includes electrolytes to help maintain fluid balance.

Laxido Laranja should be stored at ambient temperature, below 25 °C, in its original packaging to protect it from moisture. Keep the container tightly closed and out of direct sunlight to preserve product stability.

The powder is dissolved in a specified amount of water, as instructed by the prescriber, and the solution is taken orally. It is typically consumed once daily, but the exact timing and frequency depend on the therapeutic indication and individual patient needs.

Serious risks include severe electrolyte imbalances such as hyponatremia or hyperkalemia, allergic reactions ranging from rash to anaphylaxis, and rare cases of intestinal obstruction. Patients should seek immediate medical attention if they experience symptoms like severe abdominal pain, swelling, or difficulty breathing.

Laxido Laranja should be avoided in individuals with known hypersensitivity to any of its ingredients, those with severe renal impairment, uncontrolled electrolyte disorders, or intestinal blockage. It is also contraindicated in patients who have recently undergone bowel surgery without medical approval.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Sodium Hydrogen Carbonate, Potassium Chloride, Sodium Chloride, Macrogol 3350

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT